Table 1.
Antibodies.
| Primary antibody | Dilution | Secondary | Dilution | |||
|---|---|---|---|---|---|---|
| Immunofluorescence | ||||||
| MYH type IIa (DSHB, SC-71) | 1:600 | Alexa Fluor 488 IgG1 | 1:500 | |||
| MYH Type I (DSHB, BA-D5) | 1:50 | Alexa Fluor 555 IgM | 1:500 | |||
| MYH Type IIb (DSHB, BF-F3) | 1:100 | Alexa Fluor 350 IgG2b | 1:500 | |||
| PAX7 (DSHB, PAX7) | 1:10 | Alexa Fluor 488 IgG | 1:500 | |||
| |
LAM/laminin (Abcam, ab11575) |
1:500 |
|
Alexa Fluor 568 IgG |
1:500 |
|
| |
Antibody |
Dilution |
|
Notes |
||
| Immunoblotting | ||||||
| BNIP3L/Nix (Cell Signaling Technology [CST], 12396) | 1:1000 | |||||
| BNIP3 (CST, 3769) | 1:1000 | |||||
| Cre (CST 15,036) | 1:1000 | |||||
| TUBB/β-tubulin (CST 86,298) | 1:10000 | |||||
| SMAD2-SMAD3 (CST, 8685) | 1:1000 | |||||
| Phoshp-SMAD2 (CST 18,338) | 1:1000 | |||||
| MB/Myoglobin (CST 25,919) | 1:10000 | Reduced Protein (5 µg). Reduced secondary antibody (1:100,000) | ||||
| PPARGC1A/PGC1-α (Santa Cruz Biotechnology 13,067) | 1:100 | |||||
| NFE2L2/NRF2 (CST 12,721) | 1:1000 | |||||
| AIFM1/AIF1 (CST, 5318 | 1:1000 | |||||
| ATP2A/SERCA CST, 9580) | 1:1000 | |||||
| SQSTM1/p62 (CST, 5114) | 1:1000 | |||||
| LC3A (CST, 4599) | 1:1000 | |||||
| Donkey anti-rabbit HRP (Jackson Immunoresearch, 711-035-152) |
1:10000 | |||||
| Donkey anti-mouse HRP (Jackson Immunoresearch, 715-035-150) |
1:10000 | |||||
DSHB, Developmental Studies Hybridoma Bank; all DSBH antibodies used are purchased as concentrated supernatant.